cyclosporine has been researched along with Obesity in 52 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 14 (26.92) | 18.2507 |
2000's | 15 (28.85) | 29.6817 |
2010's | 18 (34.62) | 24.3611 |
2020's | 5 (9.62) | 2.80 |
Authors | Studies |
---|---|
Abe, K; Ait-Oufella, H; Alacamli, G; Alacamli, OG; Amir, O; Antar, S; Ashour, H; Azimonti, G; Baba, Y; Balogun, MM; Bampidis, V; Bastos, ML; Ben Hamouda, N; Bickel Haase, T; Bjornsson, R; Bostan, M; Braik, R; Brantom, P; Briggs, S; Bujor, I; Canbek, TD; Cherecheanu, AP; Chesson, A; Choudhary, RJ; Christensen, H; Chung, HR; Clavier, T; Dahman, NBH; Dani, S; Demailly, Z; Devine, LD; Ding, G; Duan, X; Durjava, M; Dusemund, B; Edebali, S; Elbaz Greener, G; Elnoby, AS; Fang, Q; Fares, AM; Fashola, MB; Fawzy, MS; Fouad, FM; Fu, SZ; Fujita, S; Furusawa, S; Gallagher, AM; Gao, J; Goyal, N; Guo, J; Hamuda, N; Han, Y; Hariri, G; Heist, EK; Hill, AJ; Homoud, M; Hu, Q; Hu, Z; Huang, L; Ide, T; Ikeda, M; Ishimaru, K; Jiang, C; Kaderli, ST; Kanamura, T; Karalezli, A; Kaur, P; Kazatsker, M; Kobo, O; Kouba, M; Kumar, R; Lavillegrand, JR; Leshem, E; Li, A; Li, S; Liu, R; López Puente, S; López-Alonso, M; Ma, M; Madias, C; Manini, P; Marcon, F; Margolis, G; Matsushima, S; Mayo, B; Miller, JE; Miyake, R; Miyamoto, HD; Naumann-Gola, S; Ortner, E; Pandit, R; Pang, Y; Pechová, A; Petkova, M; Pîrvulescu, R; Popa-Cherecheanu, A; Ramos, F; Roguin, A; Rozen, G; Ruskin, JN; Sanz, Y; Schweiggert-Weisz, U; Shafie, AAA; Sharma, H; Shi, X; Stoicescu, EA; Stopyra, W; Suh, JD; Sul, S; Tamion, F; Tiu, C; Tohyama, T; Tsutsui, H; Tsutsui, Y; Vandestienne, M; Villa, RE; Wang, P; Watanabe, M; Westendorf, J; Woutersen, R; Xia, J; Xing, W; Xu, X; Yang, L; Yang, N; Yu, J; Yu, M; Yu, X; Zhang, L; Zhao, Y; Zhao, Z; Zhou, X; Zorn, H | 1 |
Armstrong, AW; Connor, C; Cordoro, KM; Davis, DMR; Elewski, BE; Elmets, CA; Farley Prater, EA; Gelfand, JM; Gordon, KB; Gottlieb, AB; Hariharan, V; Kaplan, DH; Kavanaugh, A; Kiselica, M; Kivelevitch, D; Korman, NJ; Kroshinsky, D; Lebwohl, M; Leonardi, CL; Lichten, J; Lim, HW; Mehta, NN; Menter, A; Paller, AS; Parra, SL; Pathy, AL; Rupani, RN; Siegel, M; Stoff, B; Strober, BE; Wong, EB; Wu, JJ | 1 |
Calogero, A; Campanile, S; Carlomagno, N; Dodaro, C; Incollingo, P; Menkulazi, M; Peluso, G; Santangelo, ML; Scotti, A; Tammaro, V | 1 |
Altincatal, A; Berdofe, A; Centonze, D; de Moor, C; Jung, E; Kim, M; Nagpal, A; Naylor, ML; Popescu, C; Radhakrishnan, M; Rajbhandari, R; Reder, AT; Sandrock, AW; Smirnakis, K | 1 |
Jia, LQ; Jiang, XL; Kong, L; Kuang, JS; Lan, ZM; Li, Y; Lv, MJ; Song, N; Tai, H; Wu, J; Xiao, XS; Yang, GL; Yang, P; Yao, SC | 1 |
Acebes, A; Brito-Casillas, Y; Cuesto, G; De Vries, APJ; Porrini, E; Rodriguez-Rodriguez, AE; Salido, E; Torres, A; Triñanes, J; Wagner, A | 1 |
Baek, KH; Chau, GC; Seo, DS; Um, SH | 1 |
Ahn, KJ; Choe, YB; Hong, JR; Lee, YW | 1 |
Albhaisi, S; Arshad, T; Bhati, C; Driscoll, C; Lee, E; Patel, S; Reichman, T; Siddiqui, MB; Siddiqui, MS; Wolver, S | 1 |
Adamowicz, A; Brzezińska, B; Junik, R; Kamińska, A; Włodarczyk, Z | 1 |
Jiang, M; Li, F; Li, K; Luo, L; Meng, Q; Sun, C; Wang, C | 1 |
Akbas, H; Akman, S; Comak, E; Dinckan, A; Dogan, CS; Koyun, M; Uslu Gokceoglu, A | 1 |
Gipson, DS; Sethna, CB | 1 |
Kirby, B; Ryan, C | 1 |
Assenat, E; Bismuth, M; Carenco, C; Chanques, G; Danan, G; Duny, Y; Faure, S; Herrero, A; Jaber, S; Larrey, D; Navarro, F; Pageaux, GP; Ursic-Bedoya, J | 1 |
Coss, E; Dierkhising, R; Fan, C; Fussner, LA; Heimbach, JK; Leise, MD; Watt, KD | 1 |
Díez-Fuentes, ML; Fumero, C; Luis Lima, S; Porrini, E; Rodríguez-Rodríguez, AE; Salido, E; Torres, A; Triñanes, J; Vega-Prieto, MJ; Velázquez-García, S | 1 |
Gao, M; Liu, D; Qu, S; Song, K; Yan, L | 1 |
Gibson, R; Lees, CW; Lynch, RW; Pal, S; Soane, T | 1 |
Arenberger, P; Cetkovska, P; Dolezal, T; Fialova, J; Gkalpakiotis, S; Jircikova, J; Kojanova, M | 1 |
Del Giglio, M; Di Francesco, V; Girolomoni, G; Gisondi, P; Zamboni, M | 1 |
Heinen, A; Hollmann, MW; Huhn, R; Preckel, B; Schlack, W; Weber, NC | 1 |
Li, HT; Qiu, MC; Wang, ST | 1 |
Feldman, SR; Rajpara, AN | 1 |
Aarabi, M; Allabi, AC; Almond, LM; Ghobadi, C; Jamei, M; Johnson, TN; Rostami-Hodjegan, A; Rowland-Yeo, K | 1 |
Oh-i, T; Okuda, T | 1 |
Evans, S; Goldsmith, D; Gordon, I; Maclean, D; Michael, R; Taylor, J; Wells, H | 1 |
Lima, AS; Rego, LO; T D Correia, MI | 1 |
Clerbaux, G; Goffin, E; Pirson, Y | 1 |
Chan, MC; Gao, SZ; Hunt, SA; Robbins, RC; Shiba, N; Valantine, HA | 1 |
el-Agroudy, AE; Gheith, OE; Ghoneim, MA; Shehab el-Dein, AB; Wafa, EW | 1 |
Gunson, B; Johnson, J; Neuberger, J; Richards, J | 1 |
Broelsch, CE; Hoyer, PF; Kranz, B; Malagò, M; Nadalin, S; Paul, A; Schaefer, A; Vester, U; Wingen, AM | 1 |
Bora, S; Gülay, H; Kasap, B; Kavukçu, S; Soylu, A; Türkmen, M | 1 |
Davies, K; Holt, S; Tomlinson, L; Wright, DA | 1 |
Beutner, KR; Bhushan, R; Elmets, CA; Feldman, SR; Gordon, KB; Gottlieb, A; Koo, JY; Korman, NJ; Lebwohl, M; Leonardi, CL; Menter, A; Van Voorhees, AS | 1 |
Emre, S; Facklam, D; Hasse, J; Miller, C; Mor, E; Schwartz, M; Sheiner, P | 1 |
Demacker, PN; Hilbrands, LB; Hoitsma, AJ; Koene, RA; Stalenhoef, AF | 1 |
Papadavid, E; Ryan, TJ; Yell, J | 1 |
Bechstein, WO; Guckelberger, O; Jonas, S; Knoop, M; Kratschmer, B; Langrehr, JM; Lemmens, HP; Luesebrink, R; Neuhaus, P; Neuhaus, R | 1 |
Bechstein, WO; Guckelberger, O; Jonas, S; Kratschmer, B; Lemmens, HP; Luesebrink, R; Neuhaus, PL; Neuhaus, R | 1 |
Anjum, MR; Bowley, JN; Drafts, HH; Humphries, AL; Mulloy, LL; Wynn, JJ | 1 |
Canzanello, VJ; Krom, RA; Porayko, MK; Schwartz, L; Taler, SJ; Textor, SC; Wiesner, RH | 1 |
Abe, H; Hoshino, N; Kodama, M; Minouchi, T; Park, K; Shibata, N; Tomoyoshi, T; Yamaji, A | 1 |
Everhart, JE; Hoofnagle, JH; Lake, JR; Lombardero, M; Wiesner, RH; Zetterman, RK | 1 |
Hayakawa, T; Hoshino, N; Minouchi, T; Shibata, N; Uehara, M; Yamaji, A | 1 |
Furlanut, M; Wu, G | 1 |
Bonacker, U; Nägele, H; Petersen, B; Rödiger, W | 1 |
Colman, E; Fossler, M | 1 |
Alfonso, I; Armijo, JA; Boada, JN; García-Sáiz, M; López-Gil, A | 1 |
Luke, DR | 1 |
Ament, ME; Busuttil, RW; Fortunat, M; Gornbein, JA; McDiarmid, SV; Saikali, D; Vargas, JH | 1 |
4 review(s) available for cyclosporine and Obesity
Article | Year |
---|---|
Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasms; Child; Conjunctivitis, Allergic; Cornea; COVID-19; Cyclosporine; Cytokines; Death, Sudden, Cardiac; Defibrillators, Implantable; Diet; Disease Models, Animal; Docetaxel; Double-Blind Method; Dry Eye Syndromes; Educational Status; Emulsions; Female; Fluorescein Angiography; Fluoresceins; Focus Groups; Heart Failure; Hemothorax; Humans; Inflammation; Keratoconus; Male; Meibomian Glands; Mice; Middle Aged; Multiple Sclerosis; Myocardial Infarction; Myocardium; Nerve Fibers; Nigeria; Obesity; Overweight; Pandemics; Primary Prevention; Prospective Studies; Qualitative Research; Registries; Retinal Ganglion Cells; Retinal Vessels; Schools; Sirolimus; Tertiary Care Centers; Th1 Cells; Th2 Cells; Tomography, Optical Coherence; Troponin I; Tumor Necrosis Factor-alpha; United States; Ventricular Remodeling | 2022 |
Treatment of FSGS in Children.
Topics: Adrenal Cortex Hormones; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal, Murine-Derived; Antihypertensive Agents; Child; Cyclosporine; Glomerulosclerosis, Focal Segmental; Humans; Hypertension; Immunosuppressive Agents; Mycophenolic Acid; Obesity; Rituximab; Tacrolimus; Treatment Outcome; Vitamin D Deficiency | 2014 |
Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.
Topics: Acitretin; Adipokines; Alcoholism; Antibodies, Monoclonal, Humanized; Cardiovascular Diseases; Comorbidity; Cyclosporine; Dermatologic Agents; Diabetes Mellitus; Fumarates; Humans; Immunosuppressive Agents; Inflammation; Metabolic Syndrome; Methotrexate; Obesity; Psoriasis; Risk Factors; Smoking; Tumor Necrosis Factor-alpha; Ustekinumab | 2015 |
Post-liver transplant obesity and diabetes.
Topics: Cyclosporine; Diabetes Mellitus; Humans; Immunosuppressive Agents; Liver Transplantation; Obesity; Risk Factors | 2003 |
5 trial(s) available for cyclosporine and Obesity
Article | Year |
---|---|
Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasms; Child; Conjunctivitis, Allergic; Cornea; COVID-19; Cyclosporine; Cytokines; Death, Sudden, Cardiac; Defibrillators, Implantable; Diet; Disease Models, Animal; Docetaxel; Double-Blind Method; Dry Eye Syndromes; Educational Status; Emulsions; Female; Fluorescein Angiography; Fluoresceins; Focus Groups; Heart Failure; Hemothorax; Humans; Inflammation; Keratoconus; Male; Meibomian Glands; Mice; Middle Aged; Multiple Sclerosis; Myocardial Infarction; Myocardium; Nerve Fibers; Nigeria; Obesity; Overweight; Pandemics; Primary Prevention; Prospective Studies; Qualitative Research; Registries; Retinal Ganglion Cells; Retinal Vessels; Schools; Sirolimus; Tertiary Care Centers; Th1 Cells; Th2 Cells; Tomography, Optical Coherence; Troponin I; Tumor Necrosis Factor-alpha; United States; Ventricular Remodeling | 2022 |
Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial.
Topics: Combined Modality Therapy; Cyclosporine; Dermatologic Agents; Diet, Reducing; Female; Humans; Life Style; Male; Middle Aged; Obesity; Psoriasis; Severity of Illness Index; Treatment Outcome; Weight Loss | 2008 |
Weight gain and lipid profile changes in liver transplant recipients: long-term results of the American FK506 Multicenter Study.
Topics: Adult; Body Mass Index; Cholesterol; Cyclosporine; Follow-Up Studies; Humans; Liver Transplantation; Obesity; Tacrolimus; Time Factors; Triglycerides; United States; Weight Gain | 1995 |
The effects of cyclosporine and prednisone on serum lipid and (apo)lipoprotein levels in renal transplant recipients.
Topics: Adult; Apolipoproteins; Arteriosclerosis; Azathioprine; Cholesterol, HDL; Cyclosporine; Female; Graft Rejection; Humans; Hyperlipidemias; Hypertension; Kidney Diseases; Kidney Transplantation; Lipids; Lipoproteins; Male; Middle Aged; Obesity; Postoperative Complications; Prednisone; Prospective Studies; Proteinuria; Risk; Risk Factors | 1995 |
Relationship between area under the concentration versus time curve of cyclosporin A, creatinine clearance, hematocrit value, and other clinical factors in Japanese renal transplant patients.
Topics: Adult; Area Under Curve; Creatine; Cyclosporine; Female; Hematocrit; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Function Tests; Male; Middle Aged; Obesity; Regression Analysis; Tissue Donors | 1998 |
44 other study(ies) available for cyclosporine and Obesity
Article | Year |
---|---|
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients.
Topics: Adolescent; Adrenal Cortex Hormones; Anthralin; Biological Products; Calcineurin Inhibitors; Cardiovascular Diseases; Child; Child, Preschool; Coal Tar; Comorbidity; Cyclosporine; Dermatologic Agents; Dyslipidemias; Evidence-Based Medicine; Humans; Infant; Infant, Newborn; Inflammatory Bowel Diseases; Insulin Resistance; Mental Health; Metabolic Syndrome; Methotrexate; Nicotinic Acids; Obesity; Photochemotherapy; Psoriasis; Retinoids | 2020 |
Relation Between Wound Complication and Lymphocele After Kidney Transplantation: A Monocentric Study.
Topics: Adult; Aged; Cyclosporine; Delayed Graft Function; Diabetes Complications; Female; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lymphocele; Male; Middle Aged; Obesity; Retrospective Studies; Risk Factors; Sirolimus; Surgical Wound Dehiscence; Tacrolimus | 2020 |
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alemtuzumab; Azathioprine; Black or African American; Cladribine; Comorbidity; COVID-19; Crotonates; Cyclophosphamide; Cyclosporine; Databases, Factual; Dimethyl Fumarate; Female; Fingolimod Hydrochloride; Hospitalization; Humans; Hydroxybutyrates; Immunologic Factors; Immunosuppressive Agents; Incidence; Interferon-beta; Logistic Models; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mitoxantrone; Multiple Sclerosis; Mycophenolic Acid; Natalizumab; Nitriles; Obesity; Risk Factors; Rituximab; SARS-CoV-2; Toluidines; United States; White People; Young Adult | 2021 |
Tanshinone IIA combined with CsA inhibit myocardial cell apoptosis induced by renal ischemia-reperfusion injury in obese rats.
Topics: Abietanes; Animals; Apoptosis; Cyclosporine; DNA, Mitochondrial; Heart; Kidney; Male; Membrane Potential, Mitochondrial; Mitochondria, Heart; Mitochondrial Permeability Transition Pore; Myocytes, Cardiac; Obesity; Rats; Reactive Oxygen Species; Reperfusion Injury; Signal Transduction | 2021 |
Deciphering Tacrolimus-Induced Toxicity in Pancreatic β Cells.
Topics: Animals; Calcineurin; Cyclosporine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Immunosuppressive Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Nerve Tissue Proteins; NFATC Transcription Factors; Obesity; Rats; Rats, Zucker; Tacrolimus; Thinness | 2017 |
A single extra copy of Down syndrome critical region 1-4 results in impaired hepatic glucose homeostasis.
Topics: Animals; Calcineurin Inhibitors; Cyclic AMP Response Element-Binding Protein; Cyclosporine; Diet, High-Fat; Down Syndrome; Fasting; Gene Expression; Gluconeogenesis; Glucose; HEK293 Cells; Hepatocytes; Homeostasis; Humans; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Mice, Transgenic; Obesity; Phosphorylation; Transfection; Trisomy | 2019 |
Risk factors for increased serum creatinine level in patients with psoriasis treated with cyclosporine in a real-world practice.
Topics: Adult; Age Factors; Aged; Creatinine; Cyclosporine; Diabetes Mellitus; Female; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Obesity; Psoriasis; Retrospective Studies; Risk Factors | 2019 |
The Relationship Between Hypoadiponectinemia and Cardiovascular Events in Liver Transplant Recipients.
Topics: Adiponectin; Aged; Cardiovascular Diseases; Cyclosporine; Diabetes Complications; Dyslipidemias; End Stage Liver Disease; Female; Humans; Immunosuppression Therapy; Insulin Resistance; Liver Transplantation; Male; Metabolism, Inborn Errors; Middle Aged; Obesity; Proportional Hazards Models; Prospective Studies; Risk Assessment; Tacrolimus; Transplant Recipients; Treatment Outcome | 2019 |
Factors associated with glucose metabolism disorders after kidney transplantation.
Topics: Blood Glucose; Cardiovascular Diseases; Causality; Comorbidity; Cyclosporine; Female; Glucose Metabolism Disorders; Glucose Tolerance Test; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Logistic Models; Male; Middle Aged; Obesity; Overweight; Prediabetic State; Risk Factors; Tacrolimus | 2013 |
Cyclosporin A attenuates weight gain and improves glucose tolerance in diet-induced obese mice.
Topics: Adipocytes; Adipose Tissue, White; Animals; Blood Glucose; Cell Differentiation; Cyclosporine; Diabetes Mellitus, Type 2; Eating; fas Receptor; Glucose; Glucose-6-Phosphatase; Immunosuppressive Agents; Inflammation; Insulin Resistance; Interleukin-12; Interleukin-1beta; Interleukin-2; JNK Mitogen-Activated Protein Kinases; Lipid Metabolism; Mice; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Protein Serine-Threonine Kinases; Signal Transduction; Stearoyl-CoA Desaturase; Transcription Factors; Tumor Necrosis Factor-alpha; Weight Gain | 2013 |
Hyperuricemia in pediatric renal transplant recipients.
Topics: Adolescent; Child; Child, Preschool; Creatinine; Cyclosporine; Cystatin C; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hyperuricemia; Immunosuppressive Agents; Kidney Transplantation; Male; Obesity; Overweight; Prevalence; Retrospective Studies; Risk Factors; Tacrolimus; Transplantation | 2013 |
Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidence rates and risk factors.
Topics: Adult; Aged; Calcineurin Inhibitors; Cyclosporine; Female; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Neoplasms; Obesity; Risk Factors; Smoking; Tacrolimus; Transplant Recipients | 2015 |
Cardiovascular disease after liver transplantation: When, What, and Who Is at Risk.
Topics: Adult; Biomarkers; Body Mass Index; Cardiovascular Diseases; Comorbidity; Cyclosporine; Diabetes Complications; End Stage Liver Disease; Female; Glomerular Filtration Rate; Humans; Hypertension; Immunosuppression Therapy; Incidence; Liver Transplantation; Male; Metabolic Syndrome; Middle Aged; Obesity; Odds Ratio; Prevalence; Proportional Hazards Models; Retrospective Studies; Risk Factors; Tacrolimus | 2015 |
Glucose homeostasis changes and pancreatic β-cell proliferation after switching to cyclosporin in tacrolimus-induced diabetes mellitus.
Topics: Animals; Apoptosis; Calcineurin Inhibitors; Carbohydrate Metabolism; Cell Division; Cyclosporine; Diabetes Mellitus, Experimental; Drug Substitution; Glucose; Glucose Tolerance Test; Homeostasis; Insulin Resistance; Insulin-Secreting Cells; Obesity; Proinsulin; Rats; Rats, Zucker; Tacrolimus | 2015 |
Modulation of Cell-Mediated Immunity to Suppress High Fat Diet-Induced Obesity and Insulin Resistance.
Topics: Animals; Cyclosporine; Diet, High-Fat; Fingolimod Hydrochloride; Gene Expression Regulation; Immunity, Cellular; Immunosuppressive Agents; Insulin Resistance; Mice, Inbred C57BL; Obesity; Weight Gain | 2016 |
Bilateral lower limb weakness in acute severe ulcerative colitis.
Topics: Colitis, Ulcerative; Cyclosporine; Epidural Space; Glucocorticoids; Humans; Immunosuppressive Agents; Lipomatosis; Lower Extremity; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Weakness; Obesity; Prednisolone; Spinal Cord Compression; Thoracic Vertebrae | 2016 |
Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries.
Topics: Acitretin; Adult; Biological Products; Body Mass Index; Comorbidity; Coronary Disease; Cyclosporine; Czech Republic; Dermatologic Agents; Diabetes Mellitus; Female; Humans; Hyperlipidemias; Hypertension; Keratolytic Agents; Male; Methotrexate; Middle Aged; Obesity; Phototherapy; Prevalence; Psoriasis; Quality of Life; Registries; Retreatment; Retrospective Studies; Risk Factors; Severity of Illness Index | 2017 |
Cyclosporine A administered during reperfusion fails to restore cardioprotection in prediabetic Zucker obese rats in vivo.
Topics: Animals; Blood Glucose; Cyclosporine; Hemodynamics; Ischemic Postconditioning; Male; Metabolome; Methyl Ethers; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Reperfusion Injury; Myocardium; Obesity; Prediabetic State; Rats; Rats, Zucker; Sevoflurane | 2010 |
Gynecomastia, obesity and underdeveloped testis and penis: suspected hypophysitis successfully cured with low dose of cyclosporine A.
Topics: Adult; Cyclosporine; Estrogens; Gynecomastia; Humans; Male; Obesity; Penis; Pituitary Diseases; Testis; Testosterone | 2009 |
Adherence to treatment: still the forgotten variable.
Topics: Cyclosporine; Dermatologic Agents; Humans; Medication Adherence; Obesity; Psoriasis | 2010 |
Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance.
Topics: Adolescent; Adult; Aged; Benzodiazepines; Body Weights and Measures; Caffeine; Chlorzoxazone; Computer Simulation; Cyclosporine; Female; Gastrointestinal Tract; Humans; Kidney; Liver; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Obesity; Obesity, Morbid; Pharmacokinetics; Phenytoin; Regional Blood Flow; Theophylline; Young Adult | 2011 |
Cyclosporin A pharmacokinetics in a patient with psoriasis and obesity, presenting with high levels of low-density [correction for destiny] lipoprotein.
Topics: Administration, Oral; Anticholesteremic Agents; Cyclosporine; Dermatologic Agents; Drug Synergism; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hyperlipoproteinemia Type II; Immunosuppressive Agents; Indoles; Lipoproteins, LDL; Middle Aged; Obesity; Psoriasis | 2002 |
Drug interaction in a renal transplant patient: cyclosporin-Neoral and orlistat.
Topics: Administration, Oral; Anti-Obesity Agents; Cyclosporine; Diabetes Mellitus, Type 2; Drug Interactions; Humans; Immunosuppressive Agents; Injections, Intravenous; Kidney Failure, Chronic; Kidney Transplantation; Lactones; Male; Middle Aged; Obesity; Orlistat | 2003 |
Interaction between sibutramine and cyclosporine.
Topics: Adult; Appetite Depressants; Cyclobutanes; Cyclosporine; Drug Interactions; Female; Graft Rejection; Humans; Immunosuppressive Agents; Obesity | 2003 |
Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era.
Topics: Adult; Age Factors; Case-Control Studies; Coronary Artery Disease; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Multivariate Analysis; Obesity; Postoperative Complications; Risk Factors; Sex Factors; Time Factors | 2003 |
Weight gain after renal transplantation is a risk factor for patient and graft outcome.
Topics: Adult; Body Mass Index; Cause of Death; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Obesity; Postoperative Complications; Risk Factors; Survival Analysis; Weight Gain | 2004 |
Weight gain and obesity after liver transplantation.
Topics: Adolescent; Adult; Aged; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Obesity; Prospective Studies; Tacrolimus; Weight Gain | 2005 |
Development of growth and body mass index after pediatric renal transplantation.
Topics: Antibodies, Monoclonal; Basiliximab; Body Height; Body Mass Index; Child; Cyclosporine; Female; Glomerular Filtration Rate; Graft Rejection; Growth Disorders; Humans; Immunosuppressive Agents; Kidney Transplantation; Logistic Models; Male; Obesity; Prednisone; Recombinant Fusion Proteins; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Weight Gain | 2005 |
Effect of obesity and overweight on cyclosporine blood levels and renal functions in renal adolescent recipients.
Topics: Adolescent; Adult; Body Mass Index; Child; Creatinine; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Obesity; Overweight; Retrospective Studies | 2006 |
Granulomatous interstitial nephritis treated with a tumour necrosis factor-alpha inhibitor.
Topics: Antibodies, Monoclonal; Child, Preschool; Cyclosporine; Diagnostic Errors; Dwarfism; Granuloma; Hematuria; Humans; Immunosuppressive Agents; Infliximab; Male; Nephritis, Interstitial; Nephrosis, Lipoid; Nephrotic Syndrome; Obesity; Prednisolone; Proteinuria; Puberty, Delayed; Recurrence; Remission Induction; Tacrolimus; Tumor Necrosis Factor-alpha | 2006 |
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
Topics: Acitretin; Alefacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Biological Products; Cardiovascular Diseases; Cyclosporine; Depression; Etanercept; Humans; Immunoglobulin G; Interleukin-12; Interleukin-23; Lymphoma; Metabolic Syndrome; Methotrexate; Obesity; Psoriasis; PUVA Therapy; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Smoking; Tumor Necrosis Factor-alpha | 2008 |
Conjunctival oedema: a side-effect of cyclosporin and a consequence of obesity.
Topics: Adult; Conjunctival Diseases; Cyclosporine; Edema; Female; Humans; Immunosuppressive Agents; Obesity | 1996 |
Does the choice of primary immunosuppression influence the prevalence of cardiovascular risk factors after liver transplantation?
Topics: Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Cyclosporine; Follow-Up Studies; Humans; Hyperglycemia; Hypertension; Hypertriglyceridemia; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Obesity; Prevalence; Retrospective Studies; Risk Assessment; Risk Factors; Survival Rate; Tacrolimus | 1996 |
Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation.
Topics: Adolescent; Adult; Aged; Blood Glucose; Cardiovascular Diseases; Cyclosporine; Female; Follow-Up Studies; Glucocorticoids; Humans; Hypercholesterolemia; Hypertension; Hypertriglyceridemia; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Obesity; Prednisolone; Retrospective Studies; Risk Factors; Tacrolimus | 1997 |
The impact of pre-transplant obesity on renal transplant outcomes.
Topics: Adult; Azathioprine; Body Mass Index; Cadaver; Cyclosporine; Diabetes Mellitus; Female; Glucocorticoids; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Mycophenolic Acid; Obesity; Obesity, Morbid; Prednisone; Surgical Wound Infection; Survival Rate; Transplantation, Homologous; Treatment Outcome; Weight Gain | 1997 |
Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506).
Topics: Adult; Benzothiadiazines; Blood Glucose; Blood Pressure; Body Weight; Cyclosporine; Diabetes Mellitus; Diuretics; Female; Humans; Hypercholesterolemia; Hypertension; Hypertriglyceridemia; Lipids; Liver Transplantation; Male; Middle Aged; Obesity; Prednisone; Risk Factors; Sex Factors; Sodium Chloride Symporter Inhibitors; Tacrolimus | 1997 |
Weight change and obesity after liver transplantation: incidence and risk factors.
Topics: Adult; Aged; Body Mass Index; Cohort Studies; Cyclosporine; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Male; Middle Aged; Obesity; Prednisone; Risk Factors; United States; Weight Gain | 1998 |
Effect of obesity on cyclosporine trough concentrations in psoriasis patients.
Topics: Adult; Aged; Cyclosporine; Female; Fluorescence Polarization Immunoassay; Humans; Immunosuppressive Agents; Male; Middle Aged; Obesity; Psoriasis; Regression Analysis | 1998 |
Prediction of blood cyclosporine concentrations in non-obese and obese hematologic patients with multidrug resistance using total, lean and different adipose factor dosing body weights.
Topics: Adult; Body Weight; Cyclosporine; Drug Resistance, Multiple; Female; Hematologic Diseases; Humans; Male; Middle Aged; Obesity | 1999 |
Effect of orlistat on blood cyclosporin concentration in an obese heart transplant patient.
Topics: Anti-Obesity Agents; Area Under Curve; Cyclosporine; Drug Interactions; Enzyme Inhibitors; Heart Transplantation; Humans; Immunosuppressive Agents; Lactones; Lipase; Male; Obesity; Orlistat | 1999 |
Reduction in blood cyclosporine concentrations by orlistat.
Topics: Absorption; Cyclosporine; Humans; Lactones; Obesity; Organ Transplantation; Orlistat | 2000 |
Factors influencing cyclosporine blood concentration-dose ratio.
Topics: Adult; Age Factors; Bilirubin; Cholesterol; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Linear Models; Male; Middle Aged; Obesity; Organ Transplantation | 2002 |
Immunosuppressive effect of cyclosporine in the hyperlipidemic rat model.
Topics: Animals; Body Weight; Cell Division; Cyclosporine; Female; Hyperlipidemias; Immunosuppressive Agents; Lipoproteins; Obesity; Organ Size; Rats; Rats, Zucker; T-Lymphocytes | 1992 |
Serum lipid abnormalities in pediatric liver transplant patients.
Topics: Adolescent; Child; Child, Preschool; Cholesterol; Cyclosporine; Exercise; Female; Humans; Infant; Lipids; Liver; Liver Transplantation; Male; Obesity; Prednisone; Regression Analysis; Triglycerides | 1992 |